BACKGROUND: Septic shock therapies that shorten the time to physiologic and clinical recovery may result in financial savings. However, the financial implications of improving these nonmortal outcomes are not well characterized. Therefore, we quantified hospital charges associated with four outcomes: ICU length of stay, duration of invasive mechanical ventilation, duration of vasopressor use, and new renal replacement therapy.
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Clinical trials investigating new pharmaceutical agents and treatment algorithms in patients with septic shock have historically used mortality as the primary outcome. [1] [2] [3] [4] [5] [6] However, the critical care community is increasingly exploring nonmortal outcomes in clinical studies. [7] [8] [9] [10] [11] Outcomes such as quality of life, cognition, length of stay, ventilator-free days, and vasopressorfree days are important to patients, families, the health-care system, and society. [7] [8] [9] [10] [11] Therefore, improvements in these nonmortal outcomes could potentially provide justification for approval and use of new treatments. However, experience with nonmortal outcomes in septic shock studies remains limited, and a greater understanding of these outcomes would help guide outcome selection in future trials.
Sepsis is the most costly diagnosis in hospitals in the United States, with expenditures for sepsis reaching > $20 billion in 2011. 12 The financial implications of improving nonmortal outcomes, such as shortening the duration of organ support, are largely unknown. Therefore, we analyzed hospital charges for a cohort of patients hospitalized with vasopressor-dependent septic shock and estimated savings associated with shortening ICU length of stay, mechanical ventilation, and vasopressor use and avoiding renal replacement therapy.
Methods

Design and Setting
We conducted a single-center retrospective observational study using data collected for administrative and clinical purposes. The study was performed at a large tertiary care, academic medical center in the United States with a 34-bed medical ICU. The study was approved by the Vanderbilt University institutional review board (protocol No. 160861) with waiver of informed consent.
Study Population
The study population included adults with community-onset vasopressor-dependent septic shock who presented to the ED and were admitted to the medical ICU between January 1, 2011, and October 31, 2015. Inclusion criteria included the following: $ 18 years of age; an International Classification of Diseases, Ninth Revision code for septic shock (785.52); administration of a vasopressor by continuous infusion for $ 1 h; initial presentation to the ED; and direct admission from the ED to the medical ICU.
Patients with nosocomial sepsis and those treated in surgical ICUs were not included. The unit of analysis was each hospitalization, with individual patients potentially contributing multiple hospitalizations.
Study Variables and Data Collection
All data were extracted from the electronic data warehouse at the study institution, which houses clinical and administrative data, including each line item charge incurred during hospitalization. Each item (goods and services) used in the study hospital during the care of a patient is assigned a charge amount (eg, the charge amount for a chest radiograph in 2015 was $272). The charge amount associated with each item varied over time during the study period (eg, the charge for a chest radiograph in 2011 was $231). We standardized charges in this study to the amount charged in 2015; hence, charges for all patients were described in 2015 equivalent dollars. For example, a chest radiograph was assigned the same dollar amount ($272) for this analysis regardless of whether it was completed in 2011 or 2015.
Hospital admissions were divided into calendar day intervals (midnight to midnight). Each charge was classified into one of the following categories: room occupancy and professional fees, pharmacy, laboratory, radiology, procedures, anesthesia, ED, therapy, supplies, and devices. Hospital charges incurred during each day and for the entire hospitalization were calculated by summing line item charges.
An ICU day was defined as a hospital day with a charge for occupancy of an ICU bed. A ventilator day was defined as a day in which the patient received invasive mechanical ventilation through an endotracheal tube or tracheostomy. Invasive mechanical ventilation did not include noninvasive ventilation or continuation of chronic mechanical ventilation that was present before the onset of sepsis. A vasopressor day was defined as a day in which the patient received a vasopressor by continuous infusion for $ 1 h. Eligible vasopressors included norepinephrine, epinephrine, dopamine, phenylephrine, and vasopressin. New renal replacement therapy was defined as initiation of hemodialysis or continuous renal replacement therapy after hospital admission. Patients with end-stage renal disease on chronic renal replacement therapy prior to their sepsis were not eligible for new renal replacement therapy.
Analysis
Initially, total hospital charges for an entire hospitalization were compiled and summarized. Both patients who died in the hospital and those who survived to discharge contributed to total hospital charges. To demonstrate differences in hospital charges between those who died and survived, calculations were also stratified by inhospital death status (died vs survived).
Then, daily charges were evaluated. These daily charges were divided into charges that occurred on calendar days in which the patient was managed in the ICU and days managed on a hospital floor. This provided a summary for the typical charges for an ICU day and hospital floor day. Daily charges for an ICU stay were also divided into charges based on the number of days a patient had been in the ICU. This calculation provided a summary for charges on the first day of ICU care and each subsequent day. Patients contributed to daily ICU charges only for the days they were treated in the ICU. For example, a patient who remained in the ICU for 1 day contributed to daily ICU charges for ICU day 1 only; meanwhile, a patient who remained in the ICU for 3 days contributed to daily charges for ICU days 1, 2, and 3. For patients with multiple ICU stays during one hospitalization, only the first ICU stay was used for analysis of daily charges.
To guide our statistical approach for calculating charge reductions associated with shortening ICU length of stay, trajectory plots of daily ICU charges (ie, scatterplots with daily charges on the y axis and days since admission on the x axis), with loess curves by quartile groups of ICU length of stay, were created. Different trajectory patterns across quartile groups of ICU length of stay would indicate that changes in daily charges over time vary by ICU length of stay, and charge reductions associated with shortening ICU length of stay should be calculated by modeling daily ICU charges (to account for the charge associated with a 1-day reduction in the ICU varying, dependent on the ultimate duration of ICU stay). As visualized on the trajectory plot (e -Fig 1) , daily ICU charges decreased over time, and the decline rate did indeed vary by duration of ICU length of stay (ie, the longer the ICU length of stay, the slower the decline rate). Hence, we estimated charge reductions associated with a 1-day reduction in ICU length of stay by modeling daily charges against days since admission, total ICU length of stay, and their interactions using a generalized least squares linear regression model with first-order autoregressive correlated errors to account for correlation between ICU days within the same ICU stay. The interaction term was included to account for a slower decline rate with increased ICU length of stay.
For a given ICU length of stay, the charge reduction associated with shortening ICU length of stay by 1 day was calculated with the following four steps. First, daily charges on ICU day 1 were estimated. Second, the decline rate corresponding to the specific ICU length of stay (interaction term in the model) was used to calculate each subsequent daily charge and the corresponding total ICU charges. Third, the total ICU charges were estimated again using the same approach but with a decline rate corresponding to an ICU length of stay of 1 day shorter. Fourth, the charge reduction associated with shortening ICU length of stay by 1 day was estimated by taking the difference between the total ICU charges calculated in steps 2 and 3 (e-Appendix 1).
Trajectory plots were also created for duration of mechanical ventilation and vasopressor use (e- Fig 2) . The decline rate of daily charges did not appear to vary by duration of mechanical ventilation or vasopressor use. Therefore, charge reductions associated with 1-day reduction in mechanical ventilation and vasopressor use were estimated by modeling total hospital charges (not daily charges) against mechanical ventilation or vasopressor use while adjusting for the following: duration of hospital floor length of stay, and duration of ICU stay while not on mechanical ventilation (for the mechanical ventilation model) or duration of ICU stay while not using vasopressors (for the vasopressor model). Linear regression modeling with ordinary least square estimates was used for total hospital charge models where charge reductions associated with 1-day reductions in mechanical ventilation or vasopressor use were obtained as the corresponding parameter estimates.
Charge reductions associated with avoidance of renal replacement therapy were estimated by modeling total hospital charges against renal replacement therapy, while adjusting for duration of ICU stay and floor stay using a linear regression model with ordinary least square estimates.
Analyses were conducted with R version 3.2.0 (R Foundation for Statistical Computing) and STATA version 14 (StataCorp).
Results
The study population included 587 hospitalizations for community-onset, vasopressor-dependent septic shock; 568 unique patients accounted for these 587 hospitalizations. The mean age was 60 years; 180 patients (30.7%) died during the hospitalization (Table 1) . Patients stayed in the hospital a mean of 9.8 days, with 6.3 days in the ICU and the remaining 3.5 days on a medical floor (e -Fig 3) . The median ICU length of stay was 4 days (interquartile range [IQR], 2-8 days).
Total Hospital Charges and Daily Charges
The median total hospital charge for a septic shock hospitalization was $98,583 (IQR, $61,177-$136,672) (e -Fig 4) . Because of longer lengths of stay for patients who survived to discharge, total charges were higher for hospitalizations ending in discharge (median, $103,077) than death (median, $84,680); P < .01). Room occupancy and professional charges (32.9%) accounted for the largest portion of charges, followed by pharmacy, laboratory, and procedure charges ( Table 2 ).
The median daily charge for an ICU day was $13,922 (IQR, $10,271-$20,139). Daily ICU charges were highest on the first ICU day (median, $25,074) and then decreased over the next several days for patients remaining in the ICU, before stabilizing around ICU day 4 at a median of approximately $11,000 (e- Table 1 , Fig 1) . The median daily charge for a hospital floor day was $5,484 (IQR, $4,285-$7,448) (e- Fig 5) .
Charge Reductions Associated With Shorter ICU Length of Stay
Total hospital charges were strongly correlated with ICU length of stay (Spearman correlation coefficient ¼ 0.87) (e- Fig 6) . Because daily charges in the ICU varied by how long a patient had been in the ICU, the charge reduction associated with a 1-day shortening of ICU length of stay was dependent on ICU length of stay (e- Table 2 , Fig 2) . For example, shortening ICU length of stay from 3 days to 2 days was associated with a charge reduction of $18,842 (95% CI, $18,174-$19,509), whereas shortening from 10 days to 9 days was associated with a charge reduction of $12,233 (95% CI, $11,396-$13,070). The median ICU length of stay was 4 days. A 1-day reduction in ICU length of stay from 5 days to this median of 4 days was associated with a reduction in total hospital charges of $16,671 (95% CI, $16,042-$17,300) ( Table 3) .
Charge reductions associated with shortening ICU length of stay originated from two sources: reducing the total time spent in hospital and reducing daily charges for days patients were in the hospital, reflecting earlier improvement of sepsis resulting in smaller charges each day (e -Fig 7, e- Table 2 ). 
Discussion
In this study of adults with community-onset septic shock, we demonstrated a high financial burden for septic shock, with a median charge for a septic shock hospitalization of approximately $100,000. Additionally, we quantified large potential savings associated with shortening the duration of ICU length of stay, mechanical ventilation, and vasopressor use, with a 1-day reduction in any of these variables associated with a charge reduction of approximately $15,000 to $20,000. We estimated avoidance of new renal replacement therapy would reduce hospital charges by about $36,000.
Ventilator-free days, vasopressor-free days, and organ failure-free days are increasingly used as outcomes in critical care trials. [13] [14] [15] These outcomes have advantages and disadvantages. The advantages include the association of organ failure with mortality, and the ability to power trials with fewer patients than would be needed using mortality as the primary outcome. 7, 16 Our data provide further rationale for the use of these outcomes based on potential financial savings. The disadvantages of these outcomes include their composite make-up, equating prolonged organ support with death, and the subjective nature of decisions about when to transition patients off organ support. 7 From a clinical perspective, these results suggest that improvement in nonmortal outcomes can be an important goal in the management of patients who are critically ill with septic shock. Reducing the duration of organ support and ICU care appear to conserve substantial resources that could be invested toward the care of additional patients.
We reported hospital charge data in this study. Charges are the dollar amounts hospitals invoice to payers (eg, insurance companies, patients); charges are list prices provided by hospitals. Costs are the expenses incurred to deliver health-care goods and services; costs reflect true resource consumption. Although charges are typically higher than costs, costs are challenging to ascertain for many health-care activities because of the complexities of allocating specific dollar amounts for labor and facilities. In some studies, cost-to-charge ratios are applied to adjust charge data to generate estimated costs. 17 However, cost-to-charge ratios have several limitations. First, cost-to-charge ratios are usually calculated based on facility charges without considering professional charges, and may significantly underestimate professional costs when applied to professional charges. 18 Second, cost-to-charge ratios are typically calculated by dividing the amount reimbursed to hospitals by the amount charged by a hospital; however, reimbursement does not necessarily reflect true costs. 19 Finally, there is wide variation in cost-to-charge ratios across facilities. 20 Therefore, reporting charge data may be the most transparent method of presenting information on the financial impact of changes in health-care delivery. 21 With raw charge data reported in this study, readers can apply facility-specific cost-tocharge ratios, or use an average cost-to-charge ratio reported by the Centers for Medicare and Medicaid Services 22 (approximately 0.34), as desired to estimate costs based on various cost-to-charge ratio assumptions.
Our results are consistent with and add to the prior literature on the cost of septic shock hospitalizations. [23] [24] [25] . These prior studies reported costs for the combined group of severe sepsis and septic shock, whereas we focused only on septic shock. After considering the inclusion of patients who were less severely ill in the prior studies, reporting of cost estimates instead of charges, and inflation since the prior studies, our estimate for median charges for a septic shock hospitalization ($98,583) appears consistent with these prior studies. Prior work did not estimate cost savings associated with shortening ICU care, mechanical ventilation, or vasopressor use.
The strengths of our study include the detailed charge data for each ICU day and charges associated with specific therapies, such as mechanical ventilation and vasopressor use. The granularity of these data, which was largely absent from prior studies, [23] [24] [25] enabled us to estimate expected savings associated with more rapid improvement in septic shock, which is important for understanding the financial implications of improving clinical outcomes, such as ventilator-free days and vasopressor-free days.
The limitations of our study include a single-center setting and retrospective design. The reported charges reflect pricing from one academic hospital in the United States. Although trends in the charge data are expected to be generalizable, specific dollar amounts may vary among hospitals. As previously noted, we reported charges in this study, not costs. A prospective, multicenter study that collects information on resource utilization (costs) in real time (eg, measuring the time a nurse spends with each patient) would add to these findings by directly measuring resource utilization rather than relying on hospital charge data. Additionally, patients with septic shock were retrospectively identified by International Classification of Diseases, Ninth Revision code, potentially leading to some misclassification. Alternative statistical approaches that considered dynamic decision-making, such as decision trees or influence diagrams, could have been used. Our study population only included adults with vasopressor-dependent community-acquired septic shock; hence, we are unable to comment on sepsis without shock, nosocomial sepsis, and sepsis in children. Evaluating which patient characteristics are associated with more rapid clinical recovery and lower hospital charges are important topics for future investigation.
In conclusion, the median charge for septic shock hospitalizations in 2015 equivalent dollars was approximately $100,000. Shortening the duration of ICU care, mechanical ventilation, and vasopressor use and avoiding new renal replacement therapy all appear to be associated with a substantial reduction in charges. New septic shock therapies that shorten the time of ICU care and organ support have the potential to lead to substantial savings. Table 2 . 
